Trial Profile
TG 02 in patients with solid tumours.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 22 Apr 2019
Price :
$35
*
At a glance
- Drugs Zotiraciclib (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 29 Nov 2012 Status changed from unconfirmed to planning.
- 27 Nov 2012 no mention of solid tumour trials planned in latest MR, 9144046
- 13 Sep 2010 New trial record